Your browser doesn't support javascript.
COVID-19: Where is the treatment?
Sabeerabi, Bonala; Vemula, Sarojamma; Vadde, Ramakrishna; Nagaraju, Ganji Purnachandra.
  • Sabeerabi B; Department of Biochemistry, Biostandups, Hyderabad 500039, Telangana, India.
  • Vemula S; Department of Microbiology, Government Medical College, Anantapur 515001, Andhra Pradesh, India.
  • Vadde R; Department of Biotechnology & Bioinformatics, Yogi Vemana University, Kadapa 516003, Andhra Pradesh, India.
  • Nagaraju GP; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA 30322, United States. pganji@emory.edu.
World J Clin Oncol ; 12(5): 309-322, 2021 May 24.
Article in English | MEDLINE | ID: covidwho-1271031
ABSTRACT
Even though the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is related to SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), identifying effective and safe therapeutic strategies remains challenging. In search of finding effective treatments to eradicate the virus and improve disease symptoms, scientists are exploring possible therapies such as anti-viral, anti-malaria, immune therapy, and hormone treatments. However, the efficacy of these treatments was not validated on either SARS-CoV or MERS-CoV. In this study, we have reviewed synthetic evidence achieved through systematic and meta-analysis of therapeutics specific for SARS-CoV-2 and observed that the use of the above-mentioned therapies had no clinical benefits in coronavirus disease 2019 patients and, conversely, displayed side effects.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Journal: World J Clin Oncol Year: 2021 Document Type: Article Affiliation country: Wjco.v12.i5.309

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Prognostic study / Reviews / Systematic review/Meta Analysis Language: English Journal: World J Clin Oncol Year: 2021 Document Type: Article Affiliation country: Wjco.v12.i5.309